What are the main purchase channels for anamulin and how to obtain it?

Anamorelin (Anamorelin) is an oral ghrelin receptor agonist. It was originally developed by a Japanese company and is mainly used to treat cancer cachexia. It especially shows strong clinical potential in patients with non-small cell lung cancer. Cancer cachexia is a chronic metabolic syndrome, accompanied by progressive weight loss, skeletal muscle loss and decreased appetite, which seriously affects the quality of life and survival expectations. Anamorelin simulates the effect of ghrelin, promotes the release of growth hormone from the hypothalamus, enhances appetite, and increases lean body mass, thereby improving the patient's nutritional status and physical fitness.

Currently, Anamorelin has been approved for marketing in Japan under the trade nameAdlumiz, with clear indications for the treatment of cachexia symptoms in patients with advanced or unresectable solid tumors. The drug has not yet received widespread marketing approval in mainstream markets in Europe and the United States (such as FDA and EMA), so its international circulation and access are relatively limited. For non-Japanese patients, there are usually several ways to obtain Anamorelin: first, consultation through cross-border medical institutions. These institutions can help patients connect with the Japanese medical system and purchase drugs under hospital prescriptions; secondly, through international prescription drug mailing services provided by Japanese pharmacies. Some compliant pharmacies can send drugs to multiple countries including China after obtaining a doctor's prescription. In addition, some third-party medical service platforms provide drug purchasing, but these methods need to pay attention to legal compliance and drug authenticity risks.

Although the therapeutic potential of anamorelin has gained some recognition, it is not recommended that patients purchase or use it on their own, especially without the guidance of a professional doctor. In addition, because it has not yet been included in most national health insurance systems, the price of drugs is relatively high, which also makes it more difficult to obtain.

Reference materials:https://pmc.ncbi.nlm.nih.gov/articles/PMC4677053/